Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 0.60 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | BCHE | P06276 | 2/20 | 0.53 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.53 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL685837 | 0.90 | MAOB (0.68) | MAOBMAOABCHECYP4F2CYP4A11 | |
| SCHEMBL379281 | 0.89 | MAOB (0.67) | MAOBMRGPRX4MAOABCHECYP4F2 | |
| SCHEMBL12900887 | 0.89 | FFAR1 (0.58) | MAOBFFAR1NR4A2TP53POLB | |
| SCHEMBL2137838 | 0.88 | MRGPRX4 (0.69) | MAOBMRGPRX4MAOABCHECYP4F2 | |
| SCHEMBL52030 | 0.87 | MAOB (0.57) | MAOBFFAR1MAOATP53POLB | |
| SCHEMBL29378803 | 0.87 | MAOB (0.57) | MAOBFFAR1MAOATP53POLB | |
| SCHEMBL20215166 | 0.84 | KDR (0.52) | MAOBMRGPRX4FFAR1CYP4F2CYP4A11 | |
| SCHEMBL16346074 | 0.83 | GSTP1 (0.66) | MAOBMRGPRX4FFAR1BCHECYP4F2 | |
| SCHEMBL10204868 | 0.82 | MAOB (0.72) | MAOBFFAR1MAOA | |
| SCHEMBL1549250 | 0.82 | MAOB (0.68) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8313669-B2 | Liquid-crystal display | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 2012-11-20 | — | — | US | disclosed |
| US-20110101269-A1 | LIQUID-CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110101269-A1 | LIQUID-CRYSTAL DISPLAY | KLK3, LPXN, PSAP | MAOB 3582/4885MRGPRX4 3808/4885FFAR1 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.